Opko Health Inc (OPK)

Tel Aviv
Currency in ILS
517.4
-1.7(-0.33%)
Delayed Data·
OPK Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
515.3529.4
52 wk Range
427.0734.4
Key Statistics
Edit
Bid/Ask
517.40 / 518.00
Prev. Close
519.1
Open
519.1
Day's Range
515.3-529.4
52 wk Range
427-734.4
Volume
217.3K
Average Vol. (3m)
490.62K
1-Year Change
10.19%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OPK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Opko Health Inc Company Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, immunology, and infectious diseases; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins or peptides; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products for a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Spain, Ireland, Chile, and Mexico. OPKO Health, Inc. was founded in 2007 and is headquartered in Miami, Florida.

Employees
2997
Market
Israel

Compare OPK to Peers and Sector

Metrics to compare
OPK
Peers
Sector
Relationship
P/E Ratio
−17.3x11.9x−0.5x
PEG Ratio
−0.250.110.00
Price / Book
0.7x1.3x2.6x
Price / LTM Sales
1.3x1.3x2.9x
Upside (Analyst Target)
-29.0%60.8%
Fair Value Upside
Unlock19.7%10.8%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

7.04
LUNR
-5.50%
5.950
CDE
-1.33%
25.84
HIMS
-5.10%
6.240
QBTS
-2.80%
2.45
WOLF
-0.81%

FAQ

What Is the Opko Health (OPK) Stock Price Today?

The Opko Health stock price today is 517.40

What Stock Exchange Does Opko Health Trade On?

Opko Health is listed and trades on the Tel Aviv stock exchange.

What Is the Stock Symbol for Opko Health?

The stock symbol for Opko Health is "OPK."

What Is the Opko Health Market Cap?

As of today, Opko Health market cap is 3.41B.

What is Opko Health Earnings Per Share?

The Opko Health EPS is -0.08.

From a Technical Analysis Perspective, Is OPK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.